Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-079822

Chief Medical Officer sold 3,932 shares at $35.94 ($141,316)

  • Chief Medical Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Naimish Chief Medical Officer 2025-05-28 Option exercise +10,000 10,000 D
Patel Naimish Chief Medical Officer 2025-05-29 Sale −3,932 $35.94 $141,316 6,068 D
Derivatives
Patel Naimish Chief Medical Officer 2025-05-28 Option exercise · Restricted Stock Units −10,000 30,000 D
Open-market sales · 3,932 sh · avg $35.94 · $141,316
Loading xslF345X05/ownership.xml…